Skip to main content
. 2021 Mar 17;11(3):250. doi: 10.3390/life11030250

Table 1.

Current and emerging therapeutic interventions for sarcopenia with chronic liver diseases observed in clinical trials.

Target or
Mechanism of Action
Intervention Sponsor/Collaborator Clinical Phase Indication Status NCT Number Year Title
Start End
Testosterone Testosterone undecanoate Institute of Liver and Biliary Sciences, India NA Liver cirrhosis Recruiting NCT03995251 2019 2020 Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men with Cirrhosis: A Randomized Controlled Trial
Behavior Exercise University of California, San Francisco/Johns Hopkins University, Duke University NA End-stage liver disease, sarcopenia, liver cirrhosis Completed NCT02367092 2016 2019 Exercise Intervention in Liver Transplant Patients
Behavior Exercise Memorial Hospital Groups NA End-stage liver disease,
chronic liver failure, sarcopenia
Completed NCT04546048 2018 2019 The Early Strength Training Exercise Therapy in Liver Recipients: Protocol for an Observational Feasibility Trial
Behavior Pulmonary rehabilitation exercise, home-based exercise Mayo Clinic NA End-stage liver disease Recruiting NCT03266575 2018 Ongoing Does Pulmonary Rehabilitation Improve Frailty and Sarcopenia in End-Stage Liver Disease?
Dietary supplement Amino acid infusion Rigshospitalet, Denmark/Hvidovre University Hospital NA Cirrhosis Completed NCT02132962 2014 2015 Sarcopenia and Cirrhosis
Dietary supplement BCAA Puerta de Hierro University Hospital NA Sarcopenia Completed NCT04073693 2017 2019 Characterization of the Nutritional Status in the Patient with Liver Cirrhosis and Impact of a Nutritional Intervention with Nutritional Supplements with BCAA vs. Standard Treatment in the Subgroup of Patients with Sarcopenia
Dietary supplement BCAA Dayanand Medical College and Hospital 4 Liver cirrhosis Recruiting NCT03633279 2018 2020 Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients with Liver Cirrhosis—Child C: A Randomized Double Blind Control Trial
Dietary supplement BCAA Institute of Liver and Biliary Sciences, India NA Chronic liver disease Recruiting NCT04246918 2020 Ongoing Effect of Branched Chain Amino Acids Supplementation on Muscle Mass, Muscle Quality, and Molecular Markers of Muscle Regeneration in Patients With Chronic Liver Disease: A Randomized Controlled Trial
Dietary supplement HMB University of Roma La Sapienza NA Sarcopenia Completed NCT03234920 2015 2018 Effects of β-Hydroxy-β-methylbutyrate (HMB) Supplementation after Liver Transplantation: Randomized and Controlled Pilot Study
Dietary supplement CaHMB Shanghai Zhongshan Hospital NA Sarcopenia, liver cirrhosis Unknown NCT03605147 2018 2019 The Effect of Calcium β-Hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis: A Randomized Double-Blind Controlled Trial
Dietary supplement HMB University of Roma La Sapienza NA Sarcopenia, liver cirrhosis Recruiting NCT03892070 2019 2020 β-Hydroxy-β-methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: A Controlled Trial
Dietary supplement Ensure Plus Advance, Ensure High Protein Instituto Aragones de Ciencias de la Salud/Refbio2: Trans-Pyrenean Cooperation Network for Biomedical Research NA Sarcopenia, liver cirrhosis Active, not recruiting NCT03285217 2017 2019 HMB for Denutrition in Patients with Cirrhosis (HEPATIC)
Dietary supplement Fresubin energy (dietary protein energy supplement) Medical University of Graz NA Sarcopenia, liver cirrhosis Recruiting NCT03080129 2017 Ongoing Microbiome and Sarcopenia in Patients with Liver Cirrhosis: A Prospective Controlled Cohort Study
Dietary supplement Medically tailored meals, protein supplements University of Michigan NA Sarcopenia, liver cirrhosis, hepatic encephalopathy, ascites Recruiting NCT04675775 2021 Ongoing Medically Tailored Meals to Prevent Recurrent Hepatic Encephalopathy: The BRAINFOOD Pilot Trial
Multifactorial intervention Home exercise, BCAA supplements, multispecies probiotic Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau NA Sarcopenia, liver cirrhosis, frailty syndrome (FS) Recruiting NCT04243148 2020 Ongoing Frailty in Patients with Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of a Multifactorial Intervention (Home Exercise, Branched-chain Amino Acids, and Probiotics)
Multifactorial intervention Physical training program, behavioral modification therapy, nutritional consultation University of Arkansas NA End-stage liver disease, liver transplant, sarcopenia, cirrhosis Completed NCT02776553 2016 2020 A Physical Activity Program in End-Stage Liver Disease: Pilot Study Assessing Changes in Physical Fitness, Sarcopenia, and the Metabolic Profile

Data were presented in the Clinicaltrials.gov on 1 February 2021. Abbreviation: BCAA, branched chain amino acid; HMB, β-hydroxy-β-methylbutyrate; NA, not applicable.